Policy and Financing Issues for Preconception and Interconception HealthTransforming Preconceptional, Prenatal, and Interconceptional Care Into A Comprehensive Commitment To Women's Health
Introduction
It is essential that preconception, prenatal, and interconception care not be viewed as distinct entities, but rather emphasize their inherent linkages as part of a comprehensive vision of care. The danger lies in that an uncritical, business-as-usual embrace of these separate care strategies will only serve to exacerbate the discontinuities of care in what is already one of the most highly fragmented arenas of health care in the United States. To be constructive, therefore, the definition and particularly the operationalization of preconception, prenatal, and interconception care must generate greater integration and not isolation of service delivery systems. This will require new clinical and administrative practices that respect the currents of risk and clinical capacity that flow uninterrupted through these distinct arenas of care. However, the effort to ensure that preconception, prenatal, and interconception care will ultimately support integrated, comprehensive strategies of service provision must not only attend to technical and organizational considerations, it must also speak to questions of justice. This is because programs designed to improve birth outcomes are not generated exclusively by clinical or administrative insights alone. Rather, they are also deeply rooted in the fractious political debate over the best ways to alleviate the suffering of children and a longstanding societal ambivalence over the social roles of women.
Section snippets
Background: The Marginalization and Fragmentation of Childbearing Risk
A major barrier to the adoption of a more comprehensive vision of preconception, prenatal, and interconception care is the way the science of poor birth outcomes is portrayed in the world of public policy. If nothing else, the science of poor birth outcomes has been characterized by a proliferation of studies designed to identify singular risk associations, or “risk factors,” such as teenage pregnancy, maternal illicit drug use, or the lack of prenatal care (Behrman & Butler, 2007). Although
Discussion: Constructing a Comprehensive Commitment to Women's Health
In theory, all fertile women between menarche and menopause are potentially preconceptional. Although preconception care has been a useful extension of prenatal care by recognizing that childbearing risk may predate conception, it is nevertheless an anticipatory health construct predicated on intentionality. Functionally, preconception care becomes useful only when a woman intends or at least anticipates a pregnancy. If a woman does not anticipate that she will conceive in the near term, it is
Conclusion
Preconception, prenatal, and interconception care will continue to provide useful frameworks for delivering many effective services to childbearing women. This discussion does not question the intentions or focused utility of extending a concern for newborn health to both the periods before and after pregnancy. Rather, the central premise of this discussion is that preconception, prenatal, and interconception care must be extended even further and ultimately transformed into components, albeit
Dr. Wise is the Richard E. Behrman Professor of Child Health and Society and Professor of Pediatrics at Stanford University School of Medicine and the Lucile Packard Children's Hospital at Stanford. He is Director of the Center for Policy, Outcomes and Prevention and a core faculty of the Centers for Health Policy and Primary Care Outcomes Research, Stanford University.
References (11)
- et al.
Preterm birth: Causes, consequences, and prevention
(2007) - et al.
Fertility, family planning, and reproductive health of U.S. women: Data from the 2002 National Survey of Family Growth. National Center for Health Statistics
Vital Health Statistics
(2005) - et al.
National survey of the states: Policies and practices regarding drug using women
American Journal of Public Health
(1998) - et al.
Mandatory testing of pregnant women and newborns: HIV, drug use and welfare policy
Ford Urban Law Journal, XXIV
(1997) - et al.
Preconception and interconception health status of women who recently gave birth to a live-born infant—Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 26 reporting areas, 2004
MMWR
(2007)
Cited by (60)
Delivering Coordinated Cardio-Obstetric Care from Preconception through Postpartum
2021, Cardiology ClinicsInterconception Challenges of Women Who Had Prior Preterm Births
2017, JOGNN - Journal of Obstetric, Gynecologic, and Neonatal NursingCitation Excerpt :Health care providers can tailor questions to ensure that women's specific, individualized challenges are discussed during clinical encounters. Research designed to enroll women after a preterm birth, subsequent to hospital or early transition home care, is not often funded (Wise, 2008). This limits knowledge about challenges that affect women's everyday lives between pregnancies.
Child Poverty and the Promise of Human Capacity: Childhood as a Foundation for Healthy Aging
2016, Academic PediatricsPreconception and Prenatal Care
2016, Obstetrics: Normal and Problem PregnanciesInterpregnancy care
2015, Seminars in PerinatologyCitation Excerpt :Interconception care has been linked to preconception care since the latter was advanced in the 1980s and 1990s.2–6 A growing body of evidence indicated that prenatal care interventions to improve birth outcomes amounted to “too little, too late” for many women with health risks, with greater emphasis given to a life course perspective that addressed health and risks before, during, and beyond pregnancy.7,8 The evidence pointing to preconception and interconception interventions effective in improving health outcomes for women and infants was increasing.
Dr. Wise is the Richard E. Behrman Professor of Child Health and Society and Professor of Pediatrics at Stanford University School of Medicine and the Lucile Packard Children's Hospital at Stanford. He is Director of the Center for Policy, Outcomes and Prevention and a core faculty of the Centers for Health Policy and Primary Care Outcomes Research, Stanford University.
The author has no direct financial interests that might pose a conflict of interest in connection with the submitted manuscript.